• LEARN MORE ABOUT KEYNOTE 695
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact
OncoSec Medical Incorporated
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact

Quote

Investors

Investors

  • Overview
    • Profile
    • Contacts
  • Events & Presentations
  • Analysts
  • Press Releases
    • Email Alerts
  • Financial Info
  • Stock Info
    • Quote
    • Charts
    • Historical Data
  • Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • FAQ
  • Stock Info

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Contacts
  • RSS News Feed
logo

Sign Up for our mailing list to stay current on all of our exciting new research and developments.

Get Email Alerts
OncoSec’s investigational products have not been approved or cleared by the FDA.

Links

  • About
  • Pipeline
  • Technology
  • Partnering
  • Patients
  • Media
  • Investors
  • Contact
  • KEYNOTE 695 CLINICAL TRIAL

Contact

New Jersey Headquarters
820 Bear Tavern Road
Ewing, NJ 08628

R&D Laboratories
3565 General Atomics Court #100
San Diego, CA 92121

p | 855.662.6732
f | 858.430.3832

Investors@OncoSec.com


© 2023 OncoSec Medical Incorporated. All Rights Reserved. Q12-003052-01 REV E.

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.